Evidence map›Paper›PMID 20112337›Full record

ArticleInternational journal of cancer2010

Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.

Sam S Oh, Shen-Chih Chang, Lin Cai, Carlos Cordon-Cardo, Bao-Guo Ding, Sander Greenland, Na He, Qingwu Jiang, Leeka Kheifets, Anh Le and 18 more

Open access · greenAbstract read
In one paragraph

Article in International journal of cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 5 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 5 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genetic association betweenOncotarget · 2017
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 2 countries.

Sam S OhDepartment of Epidemiology, University of California, Los Angeles (UCLA) School of Public Health, Los Angeles, CA, USA.
Shen-Chih Chang
Lin Cai
Carlos Cordon-Cardo
Bao-Guo Ding
Sander Greenland
Na He
Qingwu Jiang
Leeka Kheifets
Anh Le
Yuan-Chin Amy Lee
Simin Liu
Ming-Lan Lu
Jenny T Mao
Hal Morgenstern
Li-Na Mu
Allan Pantuck
Jeanette C Papp
Sungshim Lani Park
Jian Yu Rao
Victor E Reuter
Donald P Tashkin
Hua Wang
Nai-Chieh Y You
Shun-Zhang Yu
Jin-Kou Zhao
Arie Belldegrun
Zuo-Feng Zhang
University of California, Los Angeles · USFudan University · CNMemorial Sloan Kettering Cancer Center · USColumbia University · USFujian Medical University · CNIn-Q-Tel · USJiangsu Provincial Center for Disease Control and Prevention · CNMichigan Center for Translational Pathology · USNew Mexico VA Health Care System · USTaixing People's Hospital · CNUCLA Jonsson Comprehensive Cancer CenterUniversity at Buffalo, State University of New York · USUniversity of Southern California · US

Funding

UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
STATISTICAL METHODS FOR GENE MAPPINGR01GM053275 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LANGE, KENNETH L · 1995 to 2019
$9.3M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERSU01CA096134 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAO, JENNY T · 2002 to 2007
$5.1M
Stem Cell Selection &Expansion Via HOX Gene ActivationR01CA090833 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EMERSON, STEPHEN G · 2001 to 2010
$2.6M
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERSR01DA011386 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORGENSTERN, HAL M · 1999 to 2003
$1.8M
Molecular Epidemiology and Gene-Environment InteractionR21ES011667 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 2002 to 2004
$651k
INFLAMMATORY BIOMARKERS AND HPV-ASSOCIATED ORAL PRE-CANCERR03CA128099 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LE, ANH D · 2007 to 2008
$163k
MOLECULAR EPIDEMIOLOGY OF BLADDER CANCERR01ES006718 · NIEHS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI ZHANG, ZUO-FENG · 1993 to 1995
–
HELICOBACTER PYLORI MALNUTRITION AND GASTRIC CANCERR03CA077954 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1997 to 1998
–
NCI NIH HHS CA09142NCI NIH HHS CA128099NCI NIH HHS CA90833NCI NIH HHS CA96134NCI NIH HHS P50 CA090388NCI NIH HHS R01 CA090833NCI NIH HHS R03 CA077954NCI NIH HHS R03 CA128099NCI NIH HHS T32 CA009142NCI NIH HHS U01 CA096134NIDA NIH HHS DA11386NIDA NIH HHS R01 DA011386NIEHS NIH HHS ES01167NIEHS NIH HHS ES06718NIEHS NIH HHS R21 ES011667NIGMS NIH HHS GM53275NIGMS NIH HHS R01 GM053275
6 · The paper itself

Abstract

Tobacco smoke and its metabolites are carcinogens that increase tissue oxidative stress and induce target tissue inflammation. We hypothesized that genetic variation of inflammatory pathway genes plays a role in tobacco-related carcinogenesis and is modified by tobacco smoking. We evaluated the association of 12 single nucleotide polymorphisms of 8 inflammation-related genes with tobacco-related cancers (lung, oropharynx, larynx, esophagus, stomach, liver, bladder, and kidney) using 3 case-control studies from: Los Angeles (population-based; 611 lung and 553 upper aero-digestive tract cancer cases and 1,040 controls), Taixing, China (population-based; 218 esophagus, 206 stomach, 204 liver cancer cases, and 415 controls), and Memorial Sloan-Kettering Cancer Center (hospital-based; 227 bladder cancer cases and 211 controls). After adjusting for age, education, ethnicity, gender, and tobacco smoking, IL10 rs1800871 was inversely associated with oropharyngeal cancer (CT+TT vs. CC adjusted odds ratio [aOR]: 0.69, 95% confidence interval [CI]: 0.50-0.95), and was positively associated with lung cancer among never smokers (TT vs. CT+CC aOR: 2.5, 95% CI: 1.3-5.1) and inversely with oropharyngeal cancer among ever smokers (CT+TT vs. CC aOR: 0.63, 95% CI: 0.41-0.95). Among all pooled never smokers (588 cases and 816 controls), TNF rs1799964 was inversely associated with smoking-related cancer (CC vs. CT+TT aOR: 0.36, 95% CI: 0.17-0.77). Bayesian correction for multiple comparisons suggests that chance is unlikely to explain our findings (although epigenetic mechanisms may be in effect), which support our hypotheses, suggesting that IL10 rs1800871 is a susceptibility marker for oropharyngeal and lung cancers, and that TNF rs1799964 is associated with smoking-related cancers among never smokers.

Indexed as

Polymorphism, Single NucleotideAdultCase-Control StudiesFemaleHumansInflammationLaryngeal NeoplasmsLung NeoplasmsMaleMiddle AgedNeoplasmsOropharyngeal NeoplasmsSmoking

Identifiers

PMID20112337
PMCPMC2932751
OpenAlexW2142707687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.